China grants full approval to Tuoyi (toripalimab) for advanced urothelial carcinoma – Junshi Biosciences
Shanghai Junshi Biosciences Co., Ltd. announced that the National Medical Products Administration of China has converted from conditional approval to regular approval the toripalimab injection (trade name: TUOYI,… read more.




